Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: Coupling to nitric oxide release

Cellular Signalling

Volumn 11, Issue 3, 1999, Pages 189-193

  Fimiani, Caterina ^a   Mattocks, Dwight ^a   Cavani, Francesco ^a   Salzet, Michel ^a,b   Deutsch, Dale G ^c   Pryor, Stephen ^a   Bilfinger, Thomas V ^a,c   Stefano, George B ^a,b,c  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b UNIV LILLE   (France)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

3 receptor; Anadamide; Calcium transients; Endothelia; Morphine; Nitric oxide

Indexed keywords

ANANDAMIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; NALOXONE; NITRIC OXIDE; OPIATE PEPTIDE; RIMONABANT;

ARTERY ENDOTHELIUM; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ARACHIDONIC ACIDS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HUMANS; MORPHINE; NITRIC OXIDE; POLYUNSATURATED ALKAMIDES; SIGNAL TRANSDUCTION;

EID: 0033007857     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(98)00060-6     Document Type: Article

References (31)

1. Munro S., Thomas K. L. and Abu-Shaar M. (1993) Nature 365, 61-65.
2. Stefano G. B., Liu Y. and Goligorsky M. S. (1996) J. Biol. Chem. 271, 19238-19242.
3. Stefano G. B., Hartman A., Bilfinger T. V., Magazine H. I., Liu Y., Casares F. and Goligorsky M. S. (1995) J. Biol. Chem. 270, 30290-30293.
4. Stefano G. B., Scharrer B., Smith E. M., Hughes T. K., Magazine H. I., Bilfinger T. V., Hartman A., Fricchione G. L., Liu Y. and Makman M. H. (1996) Crit. Rev. Immunol. 16, 109-144.
5. Deutsch D. G., Goligorsky M. S., Schmid P. C., Krebsbach R. J., Schmid H. H. O., Das S. K., Dey S. K., Stefano G. B., Arreaza R., Thorup C. and Moore L. (1997) J. Clin. Invest. 100, 1538-1546.
6. Stefano G. B., Salzet M., Magazine H. I. and Bilfinger T. V. (1998) J. Cardiovasc. Pharmacol 31, 813-820.
7. Stefano G. B., Salzet B. and Salzet M. (1997) Brain Res. 753, 219-224.
8. Stefano G. B., Digenis A., Spector S., Leung M. K., Bilfinger T. V., Makman M. H., Scharrer B. and Abumrad N. N. (1993) Proc. Natl. Acad. Sci. USA 90, 11099-11103.
9. Stefano G. B. and Scharrer B. (1996) Comp. Biochem. Physiol. 113C, 369-373.
10. Childers S. R., Fleming L., Konkoy C. S., Marckel D., Pacheco M., Sexton T. and Ward S. (1992) Ann. N. Y. Acad. Sci. 654, 33-51.
11. Jeon Y. J., Yang K. H., Pulaski J. T. and Kaminski N. E. (1996) Mol. Pharmacol. 50, 334-341.
12. Makman M. H., Dvorkin B. and Stefano G. B. (1995) Eur. J. Pharmacol. 273, R5-R6.
13. Radomski M. W., Palmer R. M. J. and Moncada S. (1990) Proc. Natl. Acad. Sci. USA 87, 10043-10047.
14. Stefano G. B., Hall B., Makman M. H. and Dvorkin B. (1981) Science 213, 928-930.
15. Baffy G., Sharma K., Shi W., Ziyadeh F. N. and. Williamson J. R. (1995) Biochem. Biophys. Res. Commun. 210, 378-383.
16. Loeb A. L., Longnecker D. E. and Williamson J. R. (1993) Biochem. Pharmacol. 45, 1137-1142.
17. Stefano G. B. and Kream R. M. (1982) The calcium-dependent neuronal release of dopamine and its antagonism by lithium: effects of lithium on opiate agonist and antagonist binding in the marine mollusc Mytilus edulis. In: Basic Mechanisms in the Action of Lithium (Emrich H. M., Aldenhoff J. B. and Lux H. D., Eds.), pp. 64-71. Excerpta Medica Press, Berlin.
18. Bourinet E., Soong T. W., Stea A. and Snutch T. P. (1996) Proc. Natl. Acad. Sci. USA 93, 1486-1491.
19. Fields A., Gafni M., Oron Y. and Sarne Y. (1995) Brain Res. 687, 94-102.
20. Stiene-Martin A., Mattson M. P. and Hauser K. F. (1993) Brain Res. Dev. Brain Res. 76, 189-196.
21. Hauser K. F., Stiene M. A., Mattson M. P., Elde R. P., Ryan S. E. and Godleske C. C. (1996) Brain Res. 720, 191-203.
22. Ela C., Hasin Y. and Eilam Y. (1993) J. Mol. Cell. Cardiol. 25, 599-613.
23. Lopez M. C., Chen G. J., Colombo L. L., Huang D. S., Darban H., Watzl B. and Watson R. R. (1993) Int. J. Immunopharmacol. 8, 909-918.
24. Smith F. L. and Stevens D. L. (1995) J. Pharmacol. Exp. Ther. 272, 290-299.
25. Welch S. P. and Olson K. G. (1991) Life Sci. 48, 1853-1861.
26. Sugiura T., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kishimoto S., Yamashita A. and Waku K. (1996) Biochem. Biophys. Res. Commun. 229, 58-64.
27. Sugiura T., Kodaka T., Kondo S., Nakane S., Kondo H., Waku K, Ishima Y., Watanabe K. and Yamamoto I. (1997) J. Biochem. 122, 890-895.
28. Sugiura T., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kishimoto S., Yamashita A. and Waku K. (1997) Biochem. Biophys. Res. Commun. 233, 207-210.
29. Stefano G. B., Salzet B., Rialas C. M., Pope M., Kustka A., Neenan K., Pryor S. C. and Salzet M. (1997) Brain Res. 763, 63-68.
30. Stefano G. B. (1998) J. Neuroimmunol. 83, 70-76.
31. Rialas C. M., Bilfinger T. V., Salzet M. and Stefano G. B. (1998) Acta Pharmacol. Sin. (in press).